110 related articles for article (PubMed ID: 24042156)
1. Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis.
Chen F; Qiao Q; Xu P; Fan B; Chen Z
Clin Appl Thromb Hemost; 2014 Nov; 20(8):783-92. PubMed ID: 24042156
[TBL] [Abstract][Full Text] [Related]
2. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII val34leu and the risk of myocardial infarction.
Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
[TBL] [Abstract][Full Text] [Related]
4. Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.
Jung JH; Song GG; Kim JH; Seo YH; Choi SJ
Cardiol J; 2017; 24(1):74-84. PubMed ID: 27665853
[TBL] [Abstract][Full Text] [Related]
5. Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.
Guodong Jin ; Beili Feng ; Peng Chen ; Oushan Tang ; Jian Wang ; Ji Ma ; Yuping Shi ; Geng Xu
Clin Appl Thromb Hemost; 2011 Apr; 17(2):208-13. PubMed ID: 20211923
[TBL] [Abstract][Full Text] [Related]
6. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII-A Val34Leu polymorphism might beassociated with myocardial infarction risk: an updated meta-analysis.
Wang G; Zou Z; Ji X; Ni Q; Ma Z
Int J Clin Exp Med; 2014; 7(12):5547-52. PubMed ID: 25664069
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation factor XIII-A subunit Val34Leu polymorphisms and intracerebral hemorrhage risk: A meta-analysis of case-control studies.
Ma J; Li H; You C; Liu Y; Ma L; Huang S
Br J Neurosurg; 2015; 29(5):672-7. PubMed ID: 26121426
[TBL] [Abstract][Full Text] [Related]
10. Association between the Val34Leu polymorphism in blood coagulation factor XIII-A and intracerebral hemorrhage: a meta-analysis.
Ye X; Ye B
Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525858
[TBL] [Abstract][Full Text] [Related]
11. Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke.
Shemirani AH; Pongrácz E; Antalfi B; Adány R; Muszbek L
Thromb Res; 2010 Aug; 126(2):159-62. PubMed ID: 20609463
[TBL] [Abstract][Full Text] [Related]
12. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
[TBL] [Abstract][Full Text] [Related]
13. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.
Vokó Z; Bereczky Z; Katona E; Adány R; Muszbek L
Thromb Haemost; 2007 Mar; 97(3):458-63. PubMed ID: 17334514
[TBL] [Abstract][Full Text] [Related]
14. [Factor XIII-A subunit Val34Leu polymorphism and risk of venous thromboembolism in young adults].
Demyanenko AV; Kapustin SI; Soroka VV; Chechulov PV
Angiol Sosud Khir; 2015; 21(2):21-5. PubMed ID: 26035561
[TBL] [Abstract][Full Text] [Related]
15. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
[TBL] [Abstract][Full Text] [Related]
16. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
[TBL] [Abstract][Full Text] [Related]
18. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
[TBL] [Abstract][Full Text] [Related]
19. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
